Cloning and expression of .beta.app-c100 receptor (c100-r)

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01) C12N 9/12 (2006.01) C12N 15/62 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01)

Patent

CA 2238007

The present invention relates to the cloning of .beta.APP-C100 receptor (C100- R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzheimer's Disease.

L'invention concerne le clonage du récepteur de .beta.APP-C100 (C100-R), ainsi que des cellules hôtes mises au point par génie génétique et exprimant le C100-R. Lesdites cellules peuvent être utilisées pour évaluer et cribler des médicaments et des analogues de .beta.-APP impliquée dans la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cloning and expression of .beta.app-c100 receptor (c100-r) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cloning and expression of .beta.app-c100 receptor (c100-r), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and expression of .beta.app-c100 receptor (c100-r) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1971582

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.